Related Experiment Videos
[Liver-specific lipoprotein component level in circulating immune complexes in liver diseases]
Sovetskaia Meditsina
|January 1, 1989
Summary
Specific liver lipoprotein circulating immune complexes (CIC) are frequently detected in patients with acute hepatitis B, chronic active autoimmune hepatitis, and primary biliary cirrhosis. These findings highlight CICs as potential biomarkers for liver disease diagnosis.
Area of Science:
- Immunology
- Hepatology
- Biochemistry
Background:
- Circulating immune complexes (CIC) play a role in various autoimmune and infectious diseases.
- Specific liver lipoprotein (SLL) is a component that may form CICs in liver disease.
- Accurate detection of liver disease biomarkers is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the presence and frequency of SLL-containing CICs in patients with different liver diseases.
- To evaluate the diagnostic potential of SLL CICs in distinguishing between various hepatic conditions.
Main Methods:
- Enzyme-binding immunosorption complement-fixation test was utilized for CIC detection.
- 177 subjects were examined, including 148 with liver diseases and 29 healthy controls.
- Patients with acute hepatitis B, chronic active autoimmune hepatitis, and primary biliary cirrhosis were specifically analyzed.
Main Results:
- SLL CICs were detected in 19 of 48 patients with acute hepatitis B.
- SLL CICs were found in 8 of 9 patients with chronic active autoimmune hepatitis.
- SLL CICs were identified in 18 of 20 patients with primary biliary cirrhosis.
Conclusions:
- SLL CICs are frequently detectable in patients suffering from acute hepatitis B, chronic active autoimmune hepatitis, and primary biliary cirrhosis.
- The high frequency of SLL CICs in these specific liver conditions suggests their potential as valuable diagnostic markers.
- Further research is warranted to explore the clinical utility of SLL CICs in liver disease management.